Germinal Center-dependent and -independent Immune Responses of Tumor-infiltrating B Cells in Human Cancers
Overview
Affiliations
B cells play essential roles in immunity, mainly through the production of high affinity plasma cells (PCs) and memory B (Bmem) cells. The affinity maturation and differentiation of B cells rely on the integration of B-cell receptor (BCR) intrinsic and extrinsic signals provided by antigen binding and the microenvironment, respectively. In recent years, tumor infiltrating B (TIL-B) cells and PCs (TIL-PCs) have been revealed as important players in antitumor responses in human cancers, but their interplay and dynamics remain largely unknown. In lymphoid organs, B-cell responses involve both germinal center (GC)-dependent and GC-independent pathways for Bmem cell and PC production. Affinity maturation of BCR repertoires occurs in GC reactions with specific spatiotemporal dynamics of signal integration by B cells. In general, the reactivation of high-affinity Bmem cells by antigens triggers GC-independent production of large numbers of PC without BCR rediversification. Understanding B-cell dynamics in immune responses requires the integration of multiple tools and readouts such as single-cell phenotyping and RNA-seq, in situ analyses, BCR repertoire analysis, BCR specificity and affinity assays, and functional tests. Here, we review how those tools have recently been applied to study TIL-B cells and TIL-PC in different types of solid tumors. We assessed the published evidence for different models of TIL-B-cell dynamics involving GC-dependent or GC-independent local responses and the resulting production of antigen-specific PCs. Altogether, we highlight the need for more integrative B-cell immunology studies to rationally investigate TIL-B cells as a leverage for antitumor therapies.
Li C, Wang P, Dong Z, Cao W, Su Y, Zhang J J Exp Clin Cancer Res. 2025; 44(1):91.
PMID: 40069827 PMC: 11895268. DOI: 10.1186/s13046-025-03341-7.
Construction of hot tumor classification models in gastrointestinal cancers.
Huang C, Liu G, Yeh Y, Chung S, Chang Y, Chiang N J Transl Med. 2025; 23(1):218.
PMID: 39984938 PMC: 11846462. DOI: 10.1186/s12967-025-06230-x.
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy.
Song S, Wang C, Chen Y, Zhou X, Han Y, Zhang H Cancer Immunol Immunother. 2025; 74(3):92.
PMID: 39891668 PMC: 11787113. DOI: 10.1007/s00262-024-03936-7.
Odhiambo D, Fan S, Hirbe A Cancers (Basel). 2025; 17(2).
PMID: 39857943 PMC: 11764400. DOI: 10.3390/cancers17020161.
Wu X, Huang Q, Chen X, Zhang B, Liang J, Zhang B Theranostics. 2025; 15(2):605-631.
PMID: 39744696 PMC: 11671382. DOI: 10.7150/thno.105423.